HDAC inhibitors have been shown to confer neuroprotection in experimental models of various neurodegenerative diseases, including HD [29], amyotrophic lateral sclerosis [30] and multiple sclerosis [31], even though the exact mechanisms underlying their neuroprotective actions are still elusive. Here, HDAC9 is linked to neurodegenerative disease.